Classical dendritic cells (cDCs) are rare sentinel cells specialized in the regulation of adaptive immunity. Modeling cDC development is crucial to study cDCs and harness their therapeutic potential. Here we address whether cDCs could differentiate in response to trophic cues delivered by mesenchymal components of the hematopoietic niche. We find that mesenchymal stromal cells engineered to express membrane-bound FLT3L and stem cell factor (SCF) together with CXCL12 induce the specification of human cDCs from CD34+ hematopoietic stem and progenitor cells (HSPCs). Engraftment of engineered mesenchymal stromal cells (eMSCs) together with CD34+ HSPCs creates an in vivo synthetic niche in the dermis of immunodeficient mice driving the differentiation of cDCs and CD123+AXL+CD327+ pre/AS-DCs. cDC2s generated in vivo display higher levels of resemblance with human blood cDCs unattained by in vitro-generated subsets. Altogether, eMSCs provide a unique platform recapitulating the full spectrum of cDC subsets enabling their functional characterization in vivo.

Original publication

DOI

10.1038/s41467-020-15937-y

Type

Journal article

Journal

Nat Commun

Publication Date

28/04/2020

Volume

11

Keywords

Animals, Biomarkers, Bone Marrow Cells, Cell Differentiation, Cell Membrane, Chemokine CXCL12, Cluster Analysis, Collagen, Dendritic Cells, Drug Combinations, Humans, Laminin, Membrane Proteins, Mice, Organoids, Proteoglycans, Stem Cell Niche, Stromal Cells